Exploring the perspectives of antimicrobial stewardship pharmacists in England on the subscription model for antimicrobial drugs

AMS pharmacists view the subscription model positively but highlight the need to refine product award criteria to reflect clinical implementation priorities. Their insights are critical to optimizing future delinked payment models and ensuring equitable access to novel antimicrobials.